Study links GLP-1s with serious gastrointestinal conditionsGlucagon-like peptide-1 (GLP-1) agonists are associated with an increased risk of serious medical conditions including stomach paralysis,...
Tirzepatide found to reduce body weight regardless of duration of condition and BMI before treatment3 days ago